Covance appoints Merck's Raymond Kaiser
This article was originally published in Scrip
Executive Summary
Drug development services company Covance has appointed Dr Raymond Kaiser global science leader and vice-president for biotechnology services, replacing Dr Carl Martin who will retire from this role after 35 years at Covance. Dr Kaiser joins the company from Merck Research Laboratories where he was executive director of bioprocess research and development.